Clinical trials for ivermectin have been stopped at least 2 times now due to weird reasons. First one in Australia was stopped due to apparently being too few COVID infected people. In the last couple of weeks the Oxford trial was stopped because apparently there was a supply problem with ivermectin, according to Merck.